{"abstract": "Dow Chemical\u2018s deal to buy Rohm and Haas isn\u2019t likely to become a redux of Huntsman\u2018s saga with Hexion, The Deal Professor says.", "web_url": "https://dealbook.nytimes.com/2008/12/30/why-dow-rohm-is-no-huntsman-hexion/", "snippet": "Dow Chemical\u2018s deal to buy Rohm and Haas isn\u2019t likely to become a redux of Huntsman\u2018s saga with Hexion, The Deal Professor says.", "lead_paragraph": "The markets are full of speculation this week about the fate of Dow Chemical\u2018s $15 billion deal to buy Rohm and Haas. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Why Dow-Rohm Is No Huntsman-Hexion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-12-30T21:54:40+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Steven Davidoff Solomon", "person": [{"firstname": "Steven", "middlename": "Davidoff", "lastname": "Solomon", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/3ce3abdb-b819-5ee3-af33-f11b10eccb14", "word_count": 968, "uri": "nyt://article/3ce3abdb-b819-5ee3-af33-f11b10eccb14"}